|

Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)

RECRUITINGN/ASponsored by University Hospital, Toulouse
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Toulouse
Started2023-02-27
Est. completion2025-12-31
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05472883

Summary

This study focuses on identifying potentially predictive human circulating adipocyte and muscle biomarkers of diabetes remission after bariatric surgery in obese type 2 diabetic (T2D) subjects.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Obese patients of at least grade 2 (body mass index ≥ 35 kg/m²)
* Type 2 diabetics
* About to undergo bariatric surgery at the Toulouse University Hospital
* Affiliated or beneficiaries of a social security plan.
* Having provided a free, informed and written consent, signed

Exclusion Criteria:

* Type 1 diabetic subjects or Maturity-Onset Diabetes of the Youth.
* Pregnant and breastfeeding women.
* Vulnerable persons as defined in the Public Health Code: protected adults (guardianship, curators), unable to express their consent.

Conditions2

DiabetesType 2 Diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.